Alira Health

CDMO Medtech

Strategic Support for Your Success

The medtech CDMO sector is evolving rapidly, driven by advancements in manufacturing, regulatory shifts, and increasing global demand for medical devices. Successfully managing differing economic environments, historical manufacturing capabilities, and established OEMs in each region remains critical for both CDMOs and medtech companies.

A clear strategy is key to success, whether you are a CDMO looking to expand capabilities, innovate in high-demand areas, or grow through investments and M&A, or a company searching for the right CDMO to strengthen your supply chain and market reach. That’s where our team comes in, offering the expertise and guidance needed to make informed decisions, enhance competencies, and drive long-term growth.

CDMO Selection

Our service portfolio includes:

Transaction Advisory
  • M&A sell-side
  • M&A buy-side
  • Carve-outs
  • Divestments
Strategy Advisory
  • Commercial due diligence
  • Growth strategy in white spaces
  • Portfolio rationalization
  • Post-merger integration
  • Pre-commercial value assessment
  • Value chain integration strategies

Why Work With Us?

CDMO Medtech featured solution
The 2026 Global Medtech Contract Development and Manufacturing Report 
The latest edition of our annual report explores the key trends shaping outsourcing strategies, deal activity, and capability development across the industry in 2026.

Selected Transactions

Contact us to learn about our full track record! 

Michal Raciborski

In today’s complex healthcare landscape, contract manufacturers face growing pressure to ensure regulatory compliance, speed up time-to-market, and control costs—while still driving innovation and managing heavy CAPEX. At Alira Health, we offer strategic advisory to help CDMOs make high-impact decisions and guide investors toward the right acquisitions. With deep industry expertise across the entire value chain—from raw materials and manufacturing processes to end markets—we help clients anticipate shifts, align with long-term value creation, and build resilient, future-ready business models.

Latest Expert Insight

Learn how pharma and medtech convergence is reshaping drug delivery system partner selection, from combination products and regulatory readiness to integrated execution.

Contact Us to Learn How We Can Support Your Needs

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.